Skip to main content
TipRanks
Go Ultimate75% OFF

Bio-Techne (TECH) Ownership - Who Owns Bio-Techne?

536 Followers

Bio-Techne (TECH) Ownership Overview

  • 0.33% Insiders
  • 35.45% Mutual Funds
  • 15.76% Other Institutional Investors
  • 28.86% ETFs
  • 19.59% Public Companies and Individual Investors

The ownership structure of Bio-Techne (TECH) stock is a mix of institutional, retail, and individual investors. Approximately 80.07% of the company’s stock is owned by Institutional Investors, 0.33% is owned by Insiders, and 19.59% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
May 11, 2026Amy E. Herr$320,386
Feb 18, 2026Amy E. Herr$116,782

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026Royce & Associates Llc$19,716,551
Sep 30, 2026Weitz Investment Management, Inc.$18,284,181
Sep 30, 2026 $1,032,726,488
Sep 30, 2026Gamco Investors, Inc. Et Al$2,670,520

Top Shareholders

TECH top shareholders
Holder# of SharesType% HoldingValue
Vanguard15,840,908Institution10.08%1,153,218,102
Vanguard Index Funds14,683,425Institution9.35%1,068,953,340
BlackRock, Inc.14,250,400Institution9.07%1,037,429,120
Ishares8,487,474Institution5.40%617,888,107
David Costen Haley6,825,000Institution4.34%496,860,000
Spdr6,200,672Institution3.95%451,408,922
Fidelity Contrafund6,042,490Institution3.85%439,893,272
Invesco4,269,339Institution2.72%310,807,879
Ivy Funds4,190,083Institution2.67%305,038,042
Smallcap World Fund Inc3,593,129Institution2.29%261,579,791

Top Mutual Fund Holders

TECH top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds14,683,425Institution9.35%1,068,953,340
Fidelity Contrafund6,042,490Institution3.85%439,893,272
Ivy Funds4,190,083Institution2.67%305,038,042
Smallcap World Fund Inc3,593,129Institution2.29%261,579,791
Fidelity Concord Street Trust2,809,107Institution1.79%204,502,990
Eaton Vance Growth Trust2,604,519Institution1.66%189,608,983
Trust For Professional Managers2,126,218Institution1.35%154,788,670
Neuberger Berman Equity Funds1,896,350Institution1.21%138,054,280
Mfs Series Trust Iv1,814,878Institution1.16%132,123,118
Sequoia Fund Inc1,385,711Institution0.88%100,879,761

Top ETF Holders

TECH top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total Stock Market ETF, VTI ETF4,980,632Institution3.17%360,946,401
Vanguard S&P 500 ETF, VOO ETF4,111,026Institution2.62%297,926,054
Vanguard Small-Cap ETF, VB ETF3,530,408Institution2.25%255,848,668
Invesco S&P 500 Equal Weight ETF, RSP ETF2,820,964Institution1.80%205,366,179
Sequoia ETF, SEQ ETF2,269,169Institution1.44%165,195,503
iShares Core S&P 500 ETF, IVV ETF2,100,849Institution1.34%152,941,807
Vanguard Small-Cap Growth ETF, VBK ETF1,962,851Institution1.25%142,247,812
State Street SPDR S&P 500 ETF Trust, SPY ETF1,937,653Institution1.23%141,138,645
SPDR S&P 500 ETF Trust CDI, AU:SPY ETF1,867,381Institution1.19%119,475,036
First Trust NYSE Arca Biotechnology Index Fund, FBT ETF1,387,978Institution0.88%101,044,798

FAQ

Who Owns Bio-Techne (TECH)?
According to the latest TipRanks data, approximately 80.07% of the company's stock is held by institutional investors, 0.33% is held by insiders, and 19.59% is held by public companies and individual investors.
What percentage of Bio-Techne (TECH) stock is held by institutional investors?
According to the latest TipRanks data, approximately 80.07% of Bio-Techne (TECH) stock is held by institutional investors: 35.45% by mutual funds, 28.86% by ETFs and 15.76% by other institutional investors.
What percentage of Bio-Techne (TECH) stock is held by retail investors?
According to the latest TipRanks data, approximately 19.59% of Bio-Techne (TECH) stock is held by public companies and individual investors.
Who owns the most shares of Bio-Techne (TECH)?
Vanguard owns the most shares of Bio-Techne (TECH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.